Vladimir Shalgunov
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein.
Journal: Journal of Parkinson's disease
Published: April 17, 2026
Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier.
Journal: Molecular pharmaceutics
Published: November 06, 2025
Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer.
Journal: EJNMMI research
Published: July 08, 2025
Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain.
Journal: ACS chemical neuroscience
Published: June 25, 2025
Head-to-Head Comparison of the in Vivo Performance of Highly Reactive and Polar 18F-Labeled Tetrazines.
Journal: Molecular pharmaceutics
Published: March 13, 2025
An 211At-labeled Tetrazine for Pretargeted Therapy.
Journal: Journal of medicinal chemistry
Published: February 18, 2025
Astatine-211-Towards In Vivo Stable Astatine-211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications.
Journal: Medicinal research reviews
Published: January 29, 2025
Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks.
Journal: Nature communications
Published: January 02, 2025
[68Ga]Ga-DOTAGA-Glu(FAPi)2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging.
Journal: Diagnostics (Basel, Switzerland)
Published: August 15, 2024
Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin - A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE.
Journal: Nuclear medicine and biology
Published: December 26, 2023
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine.
Journal: Nuclear medicine and biology
Published: October 15, 2023
Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines.
Journal: European journal of medicinal chemistry
Published: June 30, 2023
Last Updated: 09/26/2026